Are you Dr. Brewster?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 100 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Abenaa Brewster, MD is an oncologist in Houston, Texas. She is currently licensed to practice medicine in Texas, Florida, and Oklahoma. She is affiliated with University of Texas M.D. Anderson Cancer Center and is an Associate Professor of Medicine at University Tex Houston.
Education & Training
Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1998 - 2002- Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Harvard Medical SchoolClass of 1995
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2002 - 2025
OK State Medical License 2020 - 2021
MD State Medical License 1998 - 2002
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Breast Cancers: Risk Factors Among Mexican Women in Mexico, Mexican-American and African-American Women in the U.S. Start of enrollment: 2007 Jan 01
- Psychosocial Outcomes and Contralateral Prophylactic Mastectomy (CPM) Start of enrollment: 2014 Feb 24
- Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer Start of enrollment: 2017 Apr 28
Publications & Presentations
PubMed
- 19 citationsA phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab tr...Bora Lim, Rashmi Krishna Murthy, Jangsoon Lee, S. Jackson, Toshiaki Iwase
British Journal of Cancer. 2019-05-17 - 14 citationsA phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-βClinton Yam, Rashmi Krishna Murthy, Gaiane M. Rauch, James L. Murray, Ronald S. Walters
Investigational New Drugs. 2018-10-11 - 58 citationsCancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiencyRachel L. Atkinson, Wei T. Yang, Daniel G. Rosen, Melissa D. Landis, Helen Wong
Breast Cancer Research. 2013-09-04
Press Mentions
MD Anderson Research Highlights: ASCO 2023 Special EditionMay 25th, 2023- Black Women and the Breast Cancer Disparity ExplainedOctober 7th, 2021
Could Your Hair Coloring Routine Affect Your Breast Cancer Risk?December 11th, 2019- Join now to see all
Professional Memberships
- Member
